Kontopoulou L, Vasara E, Paraskevadaki E, Karpetas G, Papathanasiou IV and Gourgoulianis KI: Dietary supplementation practices among undergraduate students in greece during the COVID-19 pandemic and their association with COVID-19-related Anxiety. Mater Sociomed. 35:140–147. 2023.PubMed/NCBI View Article : Google Scholar

Silva C, Fonseca C, Ferreira R, Pinho L, Schneider BC, Weidner A, Morgado B and Lopes MJ: Depression in older adults during the COVID-19 pandemic: A systematic review protocol. BMJ Open. 12(e065610)2022.PubMed/NCBI View Article : Google Scholar

COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 398:1700–1712. 2021.PubMed/NCBI View Article : Google Scholar

Kokota D, Lund C, Ahrens J, Breuer E and Gilfillan S: Evaluation of mhGAP training for primary healthcare workers in Mulanje, Malawi: A quasi-experimental and time series study. Int J Ment Health Syst. 14(3)2020.PubMed/NCBI View Article : Google Scholar

McCarthy J, Minsky ML, Rochester N and Shannon CE: A Proposal for the Dartmouth Summer Research Project on Artificial Intelligence, August 31, 1955. AI Magazine. 27:12–15. 2006.

Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, et al: Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 69:127–157. 2019.PubMed/NCBI View Article : Google Scholar

Zakhem GA, Fakhoury JW, Motosko CC and Ho RS: Characterizing the role of dermatologists in developing artificial intelligence for assessment of skin cancer. J Am Acad Dermatol. 85:1544–1556. 2021.PubMed/NCBI View Article : Google Scholar

Wu W, Zhang Y, Jiang J, Lucas MV, Fonzo GA, Rolle CE, Cooper C, Chin-Fatt C, Krepel N, Cornelssen CA, et al: An electroencephalographic signature predicts antidepressant response in major depression. Nat Biotechnol. 38:439–447. 2020.PubMed/NCBI View Article : Google Scholar

Nothdurfter C, Eser D, Schüle C, Zwanzger P, Marcuse A, Noack I, Möller HJ, Rupprecht R and Baghai TC: The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 7:162–170. 2006.PubMed/NCBI View Article : Google Scholar

Hays R: The relevance of medical history to current practice. Aust J Gen Pract. 53:157–160. 2024.PubMed/NCBI View Article : Google Scholar

Trifu S, Sevcenco A, Stănescu M, Drăgoi AM and Cristea MB: Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (Review). Exp Ther Med. 22(1281)2021.PubMed/NCBI View Article : Google Scholar

Wilkinson ST, Agbese E, Leslie DL and Rosenheck RA: Identifying recipients of electroconvulsive therapy: Data from privately insured americans. Psychiatr Serv. 69:542–548. 2018.PubMed/NCBI View Article : Google Scholar

Spiric Z, Stojanovic Z, Samardzic R, Milovanović S, Gazdag G and Marić NP: Electroconvulsive therapy practice in Serbia today. Psychiatr Danub. 26:66–69. 2014.PubMed/NCBI

Surís A, Holliday R and North CS: The evolution of the classification of psychiatric disorders. Behav Sci (Basel). 6(5)2016.PubMed/NCBI View Article : Google Scholar

Berlin I: The Salpetriere Hospital: from confining the poor to freeing the insane. Am J Psychiatry. 160(1579)2003.PubMed/NCBI View Article : Google Scholar

Ruiz-Gomez N and Rosenstock ML: The ties that bind past and present: Tony robert-fleury, philippe pinel and the salpêtrière. Foren Sci Int Mind Law. 2(100049)2021.

Lehmann HE: Before they called it psychopharmacology. Neuropsychopharmacology. 8:291–303. 1993.PubMed/NCBI View Article : Google Scholar

Faedda GL, Becker I, Baroni A, Tondo L, Aspland E and Koukopoulos A: The origins of electroconvulsive therapy: Prof. Bini's first report on ECT. J Affect Disord. 120:12–15. 2010.PubMed/NCBI View Article : Google Scholar

Fink M: The origins of convulsive therapy. Am J Psychiatry. 141:1034–1041. 1984.

Kaliora SC, Zervas IM and Papadimitriou GN: Electroconvulsive therapy: 80 years of use in psychiatry. Psychiatriki. 29:291–302. 2018.PubMed/NCBI View Article : Google Scholar : (In Greek, Modern).

Fink M: Induced Seizures as Therapy in Man. In Larry R. Squire editor. Encyclopedia of Neuroscience. Academic Press 117-123, 2009.

Leiknes KA, Jarosh-von Schweder L and Høie B: Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2:283–344. 2012.PubMed/NCBI View Article : Google Scholar

American Psychiatric Association Task Force on Electroconvulsive Therapy: The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd edition. American Psychiatric Association, Washington, DC, 2001.

Dominiak M, Antosik-Wójcińska AZ, Goetz Z, Sikorska O, Stefanowski B, Gorostiza D and Święcicki Ł: Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: A randomized open label controlled trial. J Psychiatr Res. 133:52–59. 2021.PubMed/NCBI View Article : Google Scholar

Waite J and Easton A (eds): The ECT Handbook. 3rd edition. Royal College of Psychiatrists, London, 2013.

Stojanovic Z: Evaluation ofelectroconvulsive therapyeffects on the cognitiveandmnesticfunctionsin patients with depression. (unpublished PhDThesis). Faculty of Medicine, University of Kragujevac, 2016.(In Serbian).

Joković D, Milosavljević F, Stojanović Z, Šupić G, Vojvodić D, Uzelac B, Jukić MM and Petković Ćurčin A: CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability. Psychiatry Res. 312(114535)2022.PubMed/NCBI View Article : Google Scholar

Gurel SC, Mutlu E, Başar K and Yazıcı MK: Bi-temporal electroconvulsive therapy efficacy in bipolar and unipolar depression: A retrospective comparison. Asian J Psychiatr. 55(102503)2021.PubMed/NCBI View Article : Google Scholar

Elias A, Thomas N and Sackeim HA: Electroconvulsive Therapy in Mania: A review of 80 years of clinical experience. Am J Psychiatry. 178:229–239. 2021.PubMed/NCBI View Article : Google Scholar

Sinclair DJ, Zhao S, Qi F, Nyakyoma K, Kwong JS and Adams CE: Electroconvulsive therapy for treatment-resistant schizophrenia. Cochrane Database Syst Rev. 3(CD011847)2019.PubMed/NCBI View Article : Google Scholar

Grover S, Sahoo S, Rabha A and Koirala R: ECT in schizophrenia: A review of the evidence. Acta Neuropsychiatr. 31:115–127. 2019.PubMed/NCBI View Article : Google Scholar

Stojanovic Z and Spiric Z: Acute psychosis followed by fever-Malignant Neuroleptic Syndrome or viral encephalitis? Vojnosanit Pregl. 71:603–607. 2014.PubMed/NCBI

Morcos N, Rosinski A and Maixner DF: Electroconvulsive therapy for neuroleptic malignant Syndrome: A case series. J ECT. 35:225–230. 2019.PubMed/NCBI View Article : Google Scholar

Buday J, Albrecht J, Mareš T, Podgorná G, Horáčková K, Kališová L, Raboch J and Anders M: Brain Tumors and electroconvulsive therapy: A literature overview of the last 80 years. Front Neurol. 11(723)2020.PubMed/NCBI View Article : Google Scholar

Saeedi A, Saeedi M, Maghsoudi A and Shalbaf A: Major depressive disorder diagnosis based on effective connectivity in EEG signals: A convolutional neural network and long short-term memory approach. Cogn Neurodyn. 15:239–252. 2021.PubMed/NCBI View Article : Google Scholar

Fitzpatrick KK, Darcy A and Vierhile M: Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): A Randomized controlled trial. JMIR Ment Health. 4(e19)2017.PubMed/NCBI View Article : Google Scholar

Elvevåg B, Foltz PW, Rosenstein M and Delisi LE: An automated method to analyze language use in patients with schizophrenia and their first-degree relatives. J Neurolinguistics. 23:270–284. 2010.PubMed/NCBI View Article : Google Scholar

Antonucci LA, Raio A, Pergola G, Gelao B, Papalino M, Rampino A, Andriola I, Blasi G and Bertolino A: Machine learning-based ability to classify psychosis and early stages of disease through parenting and attachment-related variables is associated with social cognition. BMC Psychol. 9(47)2021.PubMed/NCBI View Article : Google Scholar

Bain EE, Shafner L, Walling DP, Othman AA, Chuang-Stein C, Hinkle J and Hanina A: Use of a novel artificial intelligence platform on mobile devices to assess dosing compliance in a phase 2 clinical trial in subjects with schizophrenia. JMIR Mhealth Uhealth. 5(e18)2017.PubMed/NCBI View Article : Google Scholar

du Sert OP, Potvin S, Lipp O, Dellazizzo L, Laurelli M, Breton R, Lalonde P, Phraxayavong K, O'Connor K, Pelletier JF, et al: Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial. Schizophr Res. 197:176–181. 2018.PubMed/NCBI View Article : Google Scholar

Pluijms EM, Kamperman AM, Hoogendijk WJ, Birkenhäger TK and van den Broek WW: Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: A systematic review and meta-analysis. Aust N Z J Psychiatry. 55:366–380. 2021.PubMed/NCBI View Article : Google Scholar

Ipekcioglu D, Yazar MS, Canbek O, Yuksel O, Meterelliyoz KS and Ilnem MC: Electroconvulsive therapy combined with antipsychotic therapy in the treatment of acute schizophrenia inpatients: Symptom profile of the clinical response. Psychiatry and Clinical Psychopharmacol. 28:363–370. 2018.

Pawełczyk T, Kołodziej-Kowalska E, Pawełczyk A and Rabe-Jabłońska J: Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms. Psychiatry Res. 220:175–180. 2014.PubMed/NCBI View Article : Google Scholar

Patel RS, Bachu A and Youssef NA: Combination of lithium and electroconvulsive therapy (ECT) is associated with higher odds of delirium and cognitive problems in a large national sample across the United States. Brain Stimul. 13:15–19. 2020.PubMed/NCBI View Article : Google Scholar

Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, Young RC, Sampson S, McClintock SM, Mueller M, et al: A novel strategy for continuation ECT in geriatric depression: Phase 2 of the PRIDE Study. Am J Psychiatry. 173:1110–1118. 2016.PubMed/NCBI View Article : Google Scholar

Delamarre L, Galvao F, Gohier B, Poulet E and Brunelin J: How much do benzodiazepines matter for electroconvulsive therapy in patients with major depression? J ECT. 35:184–188. 2019.PubMed/NCBI View Article : Google Scholar

Zolezzi M: Medication management during electroconvulsant therapy. Neuropsychiatr Dis Treat. 12:931–939. 2016.PubMed/NCBI View Article : Google Scholar

Kalisova L, Kubinova M, Michalec J, Albrecht J, Madlova K and Raboch J: Cognitive functioning in patients treated with electroconvulsive therapy. Neuropsychiatr Dis Treat. 14:3025–3031. 2018.PubMed/NCBI View Article : Google Scholar

Ousdal OT, Brancati GЕ, Kessler U, Erchinger V, Dale AM, Abbott C and Oltedal L: The neurobiological effects of electroconvulsive therapy studied through magnetic resonance: What Have we learned, and where do we go? Biol Psychiatry. 91:540–549. 2022.PubMed/NCBI View Article : Google Scholar

Jolly AJ and Singh SM: Does electroconvulsive therapy cause brain damage: An update. Indian J Psychiatry. 62:339–353. 2020.PubMed/NCBI View Article : Google Scholar

Falconer DW, Cleland J, Fielding S and Reid IC: Using the CambridgeNeuropsychological Test Automated Battery (CANTAB) to assess the cognitive impact ofelectroconvulsive therapy on visual and visuospatial memory. Psychol Med. 40:1017–1025. 2010.PubMed/NCBI View Article : Google Scholar

Fernie G, Bennett DM, Currie J, Perrin JS and Reid IC: Detecting objective and subjective cognitive effects of electroconvulsive therapy: Intensity, duration and test utility in a large clinical sample. Psychol Med. 44:2985–2994. 2014.PubMed/NCBI View Article : Google Scholar

Kalogerakou S, Oulis P, Anyfandi E, Konstantakopoulos G, Papakosta VM, Kontis D, Theochari E, Angelopoulos E, Zervas IM, Mellon RC, et al: Episodic Visual learning/memory and attentional flexibility in patients with major depressive disorder after clinically effective electroconvulsive therapy. J ECT. 31:246–252. 2015.PubMed/NCBI View Article : Google Scholar

Maric NP, Stojanovic Z, Andric S, Soldatovic I, Dolic M and Spiric Z: The acute and medium-term effects of treatment with electroconvulsive therapy on memory in patients with major depressive disorder. Psychol Med. 46:797–806. 2016.PubMed/NCBI View Article : Google Scholar

Stojanovic Z, Andric S, Soldatovic I, Dolic M, Spiric Z and Maric NP: Executive function in treatment-resistant depression before and after electroconvulsive therapy. World J Biol Psychiatry. 18:624–632. 2017.PubMed/NCBI View Article : Google Scholar

van Buel EM, Sigrist H, Seifritz E, Fikse L, Bosker FJ, Schoevers RA, Klein HC, Pryce CR and Eisel UL: Mouse repeated electroconvulsive seizure (ECS) does not reverse social stress effects but does induce behavioral and hippocampal changes relevant to electroconvulsive therapy (ECT) side-effects in the treatment of depression. PLoS One. 12(e0184603)2017.PubMed/NCBI View Article : Google Scholar

Maffioletti E, Carvalho Silva R, Bortolomasi M, Baune BT, Gennarelli M and Minelli A: Molecular biomarkers of electroconvulsive therapy effects and clinical response: Understanding the present to shape the future. Brain Sci. 11(1120)2021.PubMed/NCBI View Article : Google Scholar

Singh A and Kar SK: How Electroconvulsive Therapy Works?: Understanding the neurobiological mechanisms. Clin Psychopharmacol Neurosci. 15:210–221. 2017.PubMed/NCBI View Article : Google Scholar

An X and Wang Y: Electroconvulsive shock increases neurotrophy and neurogenesis: Time course and treatment session effects. Psychiatry Res. 309(114390)2022.PubMed/NCBI View Article : Google Scholar

Polyakova M, Schroeter ML, Elzinga BM, Holiga S, Schoenknecht P, de Kloet ER and Molendijk ML: Brain-Derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: Systematic review and meta-analyses of the preclinical and clinical literature. PLoS One. 10(e0141564)2015.PubMed/NCBI View Article : Google Scholar

Chen F, Danladi J, Wegener G, Madsen TM and Nyengaard JR: sustained ultrastructural changes in rat hippocampal formation after repeated electroconvulsive seizures. Int J Neuropsychopharmacol. 23:446–458. 2020.PubMed/NCBI View Article : Google Scholar

Conti G, Gale K and Kondratiev A: Immunohistochemical evaluation of the protein ekpression of nerve grovth factor and its TrkA receptor in rat limbic regions after electroshock seizures. Neurosci Res. 65:201–209. 2009.PubMed/NCBI View Article : Google Scholar

Kim J, Gale K and Kondratyev A: Effects of repeated minimal electroshock seizures on NGF, BDNF and FGF-2 protein in the rat brain during postnatal development. Int J Dev Neurosci. 28:227–232. 2010.PubMed/NCBI View Article : Google Scholar

van Zutphen EM, Rhebergen D, van Exel E, Oudega ML, Bouckaert F, Sienaert P, Vandenbulcke M, Stek M and Dols A: Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome. Transl Psychiatry. 9(155)2019.PubMed/NCBI View Article : Google Scholar

Zhang T, Tang X, Wei Y, Xu L, Hu Y, Cui H, Zeng J, Ye J, Xie Y, Tang Y, et al: Serum angioneurin levels following electroconvulsive therapy for mood disorders. Bipolar Disord. 25:671–682. 2023.PubMed/NCBI View Article : Google Scholar

Pacitti F, Bersani G, Aloe L, Caredda M, Orsi P, Quartini A, Vitali M, Ceccanti M, Tirassa P, Fiore M and Iannitelli A: Nerve growth factor serum levels in treatment-resistant schizophrenic patients following electroconvulsive therapy. Clin Ter. 171:e67–e74. 2021.PubMed/NCBI View Article : Google Scholar

Iannitelli A, Aloe L, Fiore M and Bersani G: Changes in Nerve Growth Factor plasma levels during Electroconvulsive Therapy-Variazioni nei livelli plasmatici del nerve growth factor in risposta alla terapia elettroconvulsivante. Giornale Italiano di Psicopatologia. 7:275–282. 2001.(In Italian).

Kato M, Okugawa G, Wakeno M, Takekita Y, Nonen S, Tetsuo S, Nishida K, Azuma J, Kinoshita T and Serretti A: Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects. Eur Neuropsychopharmacol. 19:718–725. 2009.PubMed/NCBI View Article : Google Scholar

Deng Y, Li W and Zhang B: Functional Activity in the Effect of Transcranial Magnetic Stimulation Therapy for Patients with Depression: A Meta-Analysis. J Pers Med. 13(405)2023.PubMed/NCBI View Article : Google Scholar

Křenek P, Hořínková J and Bartečků E: Peripheral inflammatory markers in subtypes and core features of depression: A systematized review. Psychopathology. 56:403–416. 2023.PubMed/NCBI View Article : Google Scholar

Foley ÉM, Parkinson JT, Kappelmann N and Khandaker GM: Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptoms. Compr Psychoneuroendocrinol. 8(100079)2021.PubMed/NCBI View Article : Google Scholar

Lee CH and Giuliani F: The role of inflammation in depression and fatigue. Front Immunol. 10(1696)2019.PubMed/NCBI View Article : Google Scholar

Yrondi A, Sporer M, Péran P, Schmitt L, Arbus C and Sauvaget A: Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review. Brain Stimul. 11:29–51. 2018.PubMed/NCBI View Article : Google Scholar